Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • maxing out multiplexing in mRNA seq?

    Hi all,

    We are designing an experiment in which we are interested in measuring 100+ transcriptomes using Illumina mRNA sequencing. I wonder whether anyone who is currently doing multiplexing for transcriptome analysis has any experience to share about relative depth of coverage at different levels of multiplexing. What would be the maximum number of transcriptomic samples you would be comfortable combining in a single lane with the GAII? (We work with yeast.)

    Many thanks,

    Andrea

  • #2
    Hi Andrea,

    It depends on how many sequences you will need per sample. If you are happy with 5 M sequences per sample you can combine 7-8 samples per lane (if working on a GAIIx with an expected 35-40 M sequences/lane).

    You could also combine more samples (e.g. 20-plex) and then repeat on several lanes (and in different flowcells) to gain enough sequences. This aproach migth be usefull if you would like to account for the minor differences between flowcells/runs.

    Cheers,
    Jakob

    Comment


    • #3
      Hi Andrea,

      I have done about 32 RNA-Seq libraries for S. cerevisiae. All of the GAIIx data we generate and I have had generated off-site are more in the 20-30M range, ~25M read average per lane. For all of these, I have done 4-plex to balance the bases in the index and have enough coverage for things that pop up like unmapped reads, rRNA contamination, less even coverage from mixing libraries, etc. This will change when we get our HiSeq up and running, I have been told to expect ~120M+ reads per lane and I will be able to do more samples per lane at a lower run cost. I am also moving towards strand-specific and DSN normalized, which may need more reads.

      I really like the NuGEN NGS library prep and multiplexing kit. The kit supports 8-plex, but the real benefit is that the index is in the first 4 bp of the read (5' most end). The Illumina indexing needs a second read for the index, either adding cost or reducing your first read. I made an equimolar mix of the four libraries together (BC1 - BC4, BC5 - BC8) and then I sequence in a standard SR-36 run.
      Last edited by epistatic; 01-08-2011, 11:10 AM.

      Comment


      • #4
        Results of 4-plex on two GAIIx lanes

        Multiplexed yeast mRNA-Seq, Illumina GAIIx 10/2010

        Read Counts
        Index, Lane 1, Lane 2, BC#
        ACCC, 5264469, 28367, BC1
        CGTA, 10523020, 77495, BC2
        GAGT, 6176660, 60123, BC3
        TTAG, 7077502, 199002, BC4
        AGGG, 175973, 8185099, BC5
        CCAT, 18504, 7832521, BC6
        GTCA, 26668, 7003926, BC7
        TATC, 7576, 4831595, BC8

        % of lane
        Index, Lane 1, Lane 2, BC#
        ACCC, 16.69%, 0.09%, BC1
        CGTA, 33.36%, 0.25%, BC2
        GAGT, 19.58%, 0.19%, BC3
        TTAG, 22.44%, 0.64%, BC4
        AGGG, 0.56%, 26.52%, BC5
        CCAT, 0.06%, 25.37%, BC6
        GTCA, 0.08%, 22.69%, BC7
        TATC, 0.02%, 15.65%, BC8

        Comment


        • #5
          Many thanks all!! This was very helpful.

          Comment

          Latest Articles

          Collapse

          • seqadmin
            Essential Discoveries and Tools in Epitranscriptomics
            by seqadmin




            The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...
            Yesterday, 07:01 AM
          • seqadmin
            Current Approaches to Protein Sequencing
            by seqadmin


            Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
            04-04-2024, 04:25 PM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by seqadmin, 04-11-2024, 12:08 PM
          0 responses
          55 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 04-10-2024, 10:19 PM
          0 responses
          52 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 04-10-2024, 09:21 AM
          0 responses
          45 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 04-04-2024, 09:00 AM
          0 responses
          55 views
          0 likes
          Last Post seqadmin  
          Working...
          X